Stock listing
Munich:TGK Precipio, Inc. Aktie
German listing (Munich) of Precipio, Inc. · home listing NASDAQ:PRPO
Follow Precipio, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:PRPO
$17.35 USD -1.41 (-7.5%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:PRPO
- Day range
- $17.30 – $19.11 USDNov 20, 2026
- Volume
- 35,645 sharesNov 20, 2026
- Market cap
- $31.11M USDAt the close on Nov 20, 2026 · price × 1.79M shares outstanding
- 52-week range
- $17.30 – $33.63 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $2.20M USDMedian day 43,500 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:PRPO · Home | $17.35 USD | -1.41 (-7.5%) | 35,645 | $19.00 | $19.11 | $17.30 | $18.76 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:PRPO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $17.35 | -1.41 | -7.5% | $19.00 | $19.11 | $17.30 | 35,645 | |
| $18.76 | -0.41 | -2.1% | $19.49 | $20.20 | $18.46 | 36,728 | |
| $19.17 | -0.79 | -4.0% | $20.19 | $21.19 | $18.45 | 46,092 | |
| $19.96 | -2.17 | -9.8% | $21.40 | $21.72 | $19.96 | 29,080 | |
| $22.13 | -1.12 | -4.8% | $21.99 | $22.68 | $21.82 | 14,708 | |
| $23.25 | -1.55 | -6.3% | $24.32 | $24.80 | $22.17 | 22,938 | |
| $24.80 | +1.15 | +4.9% | $23.20 | $25.03 | $22.76 | 28,890 | |
| $23.65 | +1.45 | +6.5% | $21.79 | $23.90 | $21.79 | 17,724 | |
| $22.20 | +3.58 | +19.2% | $19.00 | $22.92 | $19.00 | 47,642 | |
| $18.62 | +0.03 | +0.2% | $18.99 | $19.80 | $18.50 | 13,871 | |
| $18.59 | -0.98 | -5.0% | $18.71 | $20.24 | $18.48 | 17,116 | |
| $19.57 | +0.95 | +5.1% | $19.10 | $19.95 | $19.10 | 8,120 | |
| $18.62 | +0.83 | +4.7% | $18.35 | $19.26 | $18.00 | 17,968 | |
| $17.79 | -0.31 | -1.7% | $18.48 | $18.70 | $17.79 | 12,361 | |
| $18.10 | -1.25 | -6.5% | $19.83 | $19.83 | $17.99 | 25,900 | |
| $19.35 | +0.67 | +3.6% | $19.00 | $19.99 | $19.00 | 10,964 | |
| $18.68 | -0.23 | -1.2% | $19.10 | $19.58 | $18.68 | 25,160 | |
| $18.91 | -0.44 | -2.3% | $19.57 | $19.83 | $18.91 | 19,721 | |
| $19.35 | -0.66 | -3.3% | $19.77 | $19.84 | $19.10 | 32,988 | |
| $20.01 | -0.60 | -2.9% | $20.57 | $20.65 | $19.95 | 11,200 | |
| $20.61 | -0.64 | -3.0% | $21.20 | $21.20 | $20.47 | 27,600 | |
| $21.25 | -0.47 | -2.2% | $21.79 | $22.45 | $21.03 | 120,300 | |
| $21.72 | -0.17 | -0.8% | $21.80 | $22.52 | $21.72 | 26,600 | |
| $21.89 | +0.515 | +2.4% | $21.45 | $22.28 | $21.45 | 23,700 | |
| $21.38 | -1.165 | -5.2% | $22.29 | $22.50 | $21.38 | 95,100 | |
| $22.54 | +0.29 | +1.3% | $22.24 | $22.81 | $22.00 | 45,200 | |
| $22.25 | -0.34 | -1.5% | $22.40 | $23.17 | $22.15 | 42,500 | |
| $22.59 | 0.00 | 0.0% | $22.57 | $23.01 | $21.94 | 30,000 | |
| $22.59 | -0.53 | -2.3% | $22.90 | $23.03 | $22.20 | 12,000 | |
| $23.12 | -0.07 | -0.3% | $23.14 | $23.82 | $22.96 | 22,200 | |
| $23.19 | -0.33 | -1.4% | $23.23 | $23.72 | $22.55 | 118,000 | |
| $23.52 | +0.07 | +0.3% | $22.95 | $24.03 | $22.94 | 66,400 | |
| $23.45 | -0.55 | -2.3% | $24.00 | $24.27 | $23.30 | 18,200 | |
| $24.00 | +0.87 | +3.8% | $23.11 | $24.12 | $22.90 | 43,500 | |
| $23.13 | +0.40 | +1.8% | $22.96 | $23.95 | $22.88 | 22,700 | |
| $22.73 | -0.95 | -4.0% | $23.79 | $23.83 | $22.45 | 13,900 | |
| $23.68 | +0.10 | +0.4% | $23.72 | $24.23 | $23.63 | 74,200 | |
| $23.58 | -0.53 | -2.2% | $23.71 | $23.75 | $22.90 | 63,100 | |
| $24.11 | +0.46 | +1.9% | $23.47 | $24.36 | $23.26 | 72,400 | |
| $23.65 | -0.82 | -3.4% | $24.33 | $24.62 | $23.45 | 52,300 | |
| $24.47 | +0.63 | +2.6% | $23.87 | $24.72 | $23.23 | 58,200 | |
| $23.84 | -2.425 | -9.2% | $26.22 | $26.31 | $23.58 | 39,700 | |
| $26.27 | -0.525 | -2.0% | $26.39 | $27.04 | $26.11 | 80,500 | |
| $26.79 | +0.33 | +1.2% | $26.50 | $26.80 | $26.00 | 138,400 | |
| $26.46 | +0.02 | +0.1% | $26.38 | $26.48 | $25.74 | 192,300 | |
| $26.44 | -0.22 | -0.8% | $26.98 | $26.98 | $26.09 | 406,700 | |
| $26.66 | -0.50 | -1.8% | $27.18 | $27.19 | $25.72 | 39,100 | |
| $27.16 | -0.07 | -0.3% | $27.23 | $27.71 | $26.53 | 111,000 | |
| $27.23 | -0.09 | -0.3% | $27.20 | $27.72 | $26.90 | 62,600 | |
| $27.32 | +0.41 | +1.5% | $27.03 | $28.00 | $26.25 | 89,100 | |
| $26.91 | +1.31 | +5.1% | $25.21 | $27.41 | $25.21 | 236,300 | |
| $25.60 | -1.65 | -6.1% | $27.10 | $27.10 | $25.50 | 132,800 | |
| $27.25 | -0.15 | -0.5% | $26.87 | $27.80 | $25.63 | 304,100 | |
| $27.40 | +1.28 | +4.9% | $26.11 | $27.90 | $24.48 | 114,500 | |
| $26.12 | -1.38 | -5.0% | $27.67 | $27.96 | $25.91 | 423,800 | |
| $27.50 | -0.265 | -1.0% | $27.93 | $28.16 | $26.77 | 237,100 | |
| $27.77 | +0.075 | +0.3% | $27.41 | $28.80 | $27.06 | 211,200 | |
| $27.69 | -1.16 | -4.0% | $28.85 | $29.91 | $27.27 | 94,500 | |
| $28.85 | -0.44 | -1.5% | $29.38 | $30.55 | $28.60 | 205,200 | |
| $29.29 | -1.115 | -3.7% | $30.30 | $30.39 | $28.85 | 36,700 | |
| $30.41 | -0.445 | -1.4% | $30.43 | $32.57 | $29.57 | 91,000 | |
| $30.85 | -0.27 | -0.9% | $30.96 | $31.82 | $30.07 | 258,273 | |
| $31.12 | +0.67 | +2.2% | $30.45 | $31.41 | $29.54 | 29,686 | |
| $30.45 | +1.02 | +3.5% | $29.48 | $30.45 | $27.00 | 69,645 | |
| $29.43 | +1.58 | +5.7% | $27.76 | $29.60 | $27.10 | 366,640 |
Splits
2 splits since 2019 · NASDAQ:PRPO · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-20 | Consolidation | |
| 1-for-15 | Consolidation |
- Ticker
- Munich:TGK
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 10, 2026
Precipio Announces Q3-2026 Financial Results
Latest earnings call · Aug 17, 2026
Precipio (NASDAQ:PRPO) Q2 2026 Earnings Call
Replay and transcript
Latest deck · June 2026
Investor Presentation (June 2026)
Investor deck · 14 slides
Latest news
Precipio Announces Q3-2026 Financial Results
Nov 10, 2026
Closed $24.80 (+4.9%) on Nov 11, 2026
Precipio Announces Q3-2026 Shareholder Update Call
Oct 28, 2026
Closed $19.35 (+3.6%) on Oct 29, 2026
Precipio Announces Q2-2026 Shareholder Update Call
Jul 31, 2026
Closed $22.13 (+2.2%) on Aug 3, 2026
Precipio to Present at the Planet MicroCap Las Vegas
Jun 11, 2026
Closed $22.63 (+0.4%) on Jun 11, 2026
Precipio Announces Q1 2026 Financial Results
May 14, 2026
Closed $26.04 (-9.0%) on May 15, 2026
Management team’s 2025 market-based Options have vested
May 13, 2026
Closed $28.60 (-0.3%) on May 14, 2026
B2i Digital Welcomes Precipio, Inc. as a New Featured Company
May 11, 2026
Closed $28.68 (+0.8%) on May 12, 2026
Precipio Announces Q1-2026 Shareholder Update Call
May 6, 2026
Closed $30.40 (+1.4%) on May 7, 2026
Precipio Announces Q4 and year-end 2025 Shareholder Update Call
Mar 12, 2026
Closed $28.78 (+2.9%) on Mar 12, 2026
Precipio, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 14 in the last 12 months · 118 in all · newest Nov 10, 2026 · oldest 2019
- Calls
- 9 calls with a replay · 9 with a transcript · latest Aug 17, 2026
- Decks
- 5 decks · latest June 2026
Where Precipio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:PRPO · Home listing | NASDAQ | United States | USD |
| gettex:TGK | gettex | Germany | EUR |
| BOATS:PRPO | BOATS | United States | USD |
| LS Exchange:A3ETCE | LS Exchange | Germany | EUR |
| Munich:TGK · This page | Munich | Germany | EUR |
Valuation
EV/sales 1.0× against a median of 1.9×: 3rd lowest of 10 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $27.88M USD
- P/E
- Loss
- EV/sales
- 1.0×
- EV/EBITDA
- 119×
- Price/book
- 2.1×
- Gross margin
- 44.6%
- Operating margin
- −5.3%
- Net margin
- −4.1%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 1.00
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Precipio, Inc. · NASDAQ:PRPO | US$31.11M | US$27.88M | n/a | 1.0× | 119× | 2.1× | −4.1% | 0.0× | 1.00 |
| Trajan Group Holdings Ltd · ASX:TRJ | US$34.98M | US$65.05M | n/a | 0.6× | 7.6× | 0.5× | −0.4% | 0.6× | n/a |
| Novacyt SAS · EURONEXT:ALNOV | US$33.87M | US$35.59M | n/a | 0.8× | n/a | 1.4× | −102.4% | 0.6× | n/a |
| Rapid Micro Biosystems, Inc. · NASDAQ:RPID | US$33.56M | US$46.06M | n/a | 1.3× | n/a | 3.8× | −138.2% | 2.2× | 1.41 |
| Abnova Taiwan Corp. · TWSE:4133 | US$32.15M | US$20.35M | 23.6× | 1.9× | 13.4× | 0.8× | 13.0% | 0.0× | n/a |
| Aligned Genetics, Inc. · KRX:238120 | US$31.02M | US$28.31M | 9.0× | 2.4× | 11.8× | 1.1× | 28.7% | 0.3× | n/a |
| ENCell Co., Ltd. · KRX:456070 | US$30.74M | US$14.66M | n/a | 4.7× | n/a | 1.5× | −471.2% | 0.3× | n/a |
| LabTurbo Biotech Corporation · TPEX:7725 | US$29.75M | US$4.98M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | n/a |
| BioMark Diagnostics, Inc. · CSE:BUX | US$29.70M | US$29.15M | n/a | 1,504× | n/a | 74.6× | n/a | 0.0× | -0.11 |
| Bio Preventive Medicine Corp. · TPEX:6810 | US$29.41M | US$26.21M | n/a | 329× | n/a | 3.7× | n/a | 0.4× | n/a |
| Abingdon Health PLC · LSE:ABDX | US$28.13M | US$26.13M | n/a | 1.8× | n/a | 3.5× | −19.4% | 0.2× | n/a |
| Median of the others | US$30.88M | US$27.26M | 16.3× | 1.9× | 11.8× | 1.4× | −19.4% | 0.3× | 0.65 |
Team and board
Officers
| Officer | Role |
|---|---|
| Ilan Danieli | CEO |
| Matthew Gage | CFO |
| A. Zaki Sabet | COO |
| Miri Chiko-Radomski | Chief Legal Counsel and People Officer |
| Ayman Mohamed | CTO |
Board
| Director | Role |
|---|---|
| Richard Sandberg | Chairman of the Board |
| Christina Valauri | Director |
| David S. Cohen | Director |
| Ilan Danieli | CEO |
| Jeffrey Cossman | Director |
| Kathy LaPorte | Director |
| Ron A. Andrews | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| Precipio (NASDAQ:PRPO) Q2 2026 Earnings Call | Mon, Aug 17, 2026 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q1 2026 Earnings Call | Mon, May 18, 2026 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q4 2025 Earnings Call | Thu, Apr 02, 2026 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q3 2025 Earnings Call | Mon, Nov 17, 2025 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q2 2025 Earnings Call | Thu, May 15, 2025 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q4 2022 Earnings Call | Mon, Apr 03, 2023 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q3 2022 Earnings Call | Mon, Nov 14, 2022 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q2 2022 Earnings Call | Mon, Aug 15, 2022 · 5:00 PM ET | Replay |
| Precipio (NASDAQ:PRPO) Q4 2021 Earnings Call | Mon, Apr 04, 2022 · 5:00 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 10, 2026 · After close | +4.9% |
| Q2 2026 | Aug 14, 2026 | +3.0% |
| Q1 2026 | May 19, 2026 | −3.5% |
| Q3 2025 | Nov 14, 2025 | +7.7% |
| Q2 2025 | Aug 13, 2025 | +3.7% |
| Q1 2025 | May 12, 2025 · After close | +11.4% |
| Q4 2024 | Mar 31, 2025 · After close | −9.9% |
| Q3 2024 | Nov 11, 2024 · After close | +2.3% |
| Q2 2024 | Aug 13, 2024 · After close | −1.6% |
| Q1 2024 | May 14, 2024 · After close | −3.9% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2023 | Nov 13, 2023 · After close | −1.4% |
| Q2 2023 | Aug 11, 2023 · After close | −0.9% |
| Q1 2023 | May 12, 2023 · After close | +0.2% |
| Q4 2022 | Mar 30, 2023 · After close | +2.9% |
| Q3 2022 | Nov 10, 2022 · After close | +4.9% |
| Q2 2022 | Aug 11, 2022 · After close | +1.6% |
| Q1 2022 | May 11, 2022 · After close | +1.0% |
| Q4 2021 | Mar 30, 2022 · After close | +1.5% |
| Quarter to Sep 30, 2021 | Nov 12, 2021 · After close | −2.2% |
| Quarter to Jun 30, 2021 | Aug 12, 2021 · After close | −3.2% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2026) | Investor deck | 14 slides | June 2026 |
| Investor Presentation (August 2025) | Investor deck | 12 slides | August 2025 |
| Investor Presentation (June 2022) | Investor deck | 12 slides | Jun 13, 2022 |
| Investor Presentation (2018) | Investor deck | 17 slides | 2018 |
| IPO Roadshow (August 2017) | IPO roadshow | 23 slides | Aug 2, 2017 |
Financings
| Raise | Date |
|---|---|
| Warrant exercise of warrants Terms changed: US$1.2M Buyers: Largest warrant holder (100,000 warrants to be exercised with cash) | Jul 11, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24.0M | 18.5M | 15.2M | 9.41M | 8.85M | 6.09M | 3.13M | 2.86M | 1.72M | 1.72M |
| Cost of revenue | 13.3M | 11.0M | 9.18M | 6.90M | 6.46M | 4.94M | 2.91M | 2.64M | 1.43M | 970.0K |
| Gross profit | 10.7M | 7.56M | 6.02M | 2.51M | 2.39M | 1.15M | 219.0K | 225.0K | 292.0K | 753.0K |
| Research and development | 1.60M | 1.30M | 1.70M | 1.70M | 1.30M | 1.20M | 1.20M | 1.10M | 500.0K | 0 |
| Selling, general and administrative | 11.7M | 13.5M | 15.2M | 11.9M | 10.3M | 9.62M | 9.45M | 6.49M | 2.46M | |
| Operating income | -1.20M | -4.22M | -7.62M | -12.8M | -9.61M | -9.15M | -11.0M | -13.9M | -15.5M | -1.71M |
| Depreciation and amortization | 1.25M | 1.20M | 1.23M | 1.22M | 1.13M | 1.09M | 1.12M | 1.26M | 743.0K | 112.0K |
| EBITDA | 43.0K | -3.02M | -6.39M | -11.6M | -8.48M | -8.05M | -9.88M | -12.6M | -14.8M | -1.60M |
| Interest expense | 73.0K | 74.0K | 18.0K | 12.0K | 20.0K | 470.0K | 473.0K | 1.60M | 2.32M | 518.0K |
| Income before tax | -363.0K | -4.29M | -5.85M | -12.2M | -8.52M | -10.6M | -13.3M | -16.0M | -20.7M | -2.23M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | -70.0K | -279.0K | 349.0K | 0 |
| Net income | -363.0K | -4.29M | -5.85M | -12.2M | -8.53M | -14.0M | -13.2M | -15.7M | -20.7M | -2.23M |
| Earnings per share, basic | -0.23 | -2.93 | -4.51 | -10.73 | -0.40 | -0.85 | -2.33 | -13.82 | -7.16 | -9.44 |
| Earnings per share, diluted | -0.23 | -2.93 | -4.51 | -10.73 | -0.40 | -0.85 | -2.33 | -13.82 | -7.16 | -9.44 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.65M | 1.39M | 1.50M | 3.44M | 11.7M | 2.66M | 848.0K | 381.0K | 421.0K | 51.0K |
| Short-term investments | 0 | 0 | ||||||||
| Receivables | 1.98M | 799.0K | 1.30M | 1.04M | 697.0K | 874.0K | 574.0K | 690.0K | 730.0K | 388.0K |
| Inventory | 935.0K | 724.0K | 384.0K | 708.0K | 564.0K | 350.0K | 184.0K | 197.0K | 161.0K | 100.0K |
| Current assets | 6.04M | 3.45M | 3.68M | 5.71M | 13.5M | 4.20M | 1.88M | 1.79M | 1.74M | 552.0K |
| Property, plant and equipment | 729.0K | 719.0K | 739.0K | 877.0K | 836.0K | 277.0K | 431.0K | 496.0K | 353.0K | 280.0K |
| Goodwill | 0 | 4.68M | 0 | |||||||
| Total assets | 21.3M | 17.0M | 18.1M | 21.5M | 30.4M | 20.7M | 19.5M | 21.6M | 27.3M | 842.0K |
| Accounts payable | 1.13M | 618.0K | 622.0K | 2.04M | 1.86M | 1.69M | 1.94M | 5.17M | 5.10M | 1.08M |
| Current liabilities | 3.75M | 4.27M | 3.14M | 4.36M | 4.21M | 4.66M | 4.33M | 13.8M | 10.0M | 3.01M |
| Long-term debt | 47.0K | 77.0K | 106.0K | 134.0K | 160.0K | 362.0K | 198.0K | 253.0K | 2.83M | 4.13M |
| Total debt | 83.0K | 383.0K | 353.0K | 404.0K | 186.0K | 1.03M | 543.0K | 516.0K | 3.42M | 4.52M |
| Total liabilities | 6.76M | 4.90M | 3.67M | 5.14M | 5.83M | 6.55M | 6.31M | 15.5M | 14.2M | 7.30M |
| Shareholders' equity | 14.6M | 12.1M | 14.4M | 16.3M | 24.6M | 14.1M | 13.2M | 6.12M | 13.0M | -6.46M |
| Shares outstanding | 1.78M | 1.49M | 1.42M | 1.14M | 22.7M | 17.6M | 7.90M | 2.30M | 10.2M | 449.2K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 685.0K | 439.0K | -3.56M | -7.72M | -6.58M | -7.43M | -9.14M | -6.75M | -6.69M | -959.0K |
| Capital spending | -326.0K | -223.0K | -126.0K | -277.0K | -682.0K | -151.0K | -55.0K | -97.0K | -143.0K | -19.0K |
| Free cash flow | 359.0K | 216.0K | -3.69M | -8.00M | -7.26M | -7.58M | -9.20M | -6.85M | -6.83M | -978.0K |
| Cash from investing | -326.0K | -223.0K | -126.0K | -277.0K | -682.0K | -96.0K | -55.0K | -97.0K | -42.0K | 1.01M |
| Cash from financing | 903.0K | -329.0K | 1.74M | -225.0K | 16.3M | 9.34M | 9.66M | 6.81M | 7.10M | 775.0K |
| Dividends paid | -3.73M | 0 | 0 | |||||||
| Share buybacks | 8.93M | -1.00K | 3.28M | 7.81M | 2.26M | |||||
| Change in cash | 1.26M | -113.0K | -1.94M | -8.22M | 9.01M | 1.81M | 467.0K | -40.0K | 370.0K | -184.0K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 10, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2026 | Results | SEC |
| 8-K · Current report | Oct 29, 2026 | Current report | SEC |
| 4 · Change in ownership | Oct 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 19, 2026 | Insider trade | SEC |
| 8-K · Current report | Aug 14, 2026 | Results | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2026 | Current report | SEC |
| 4 · Change in ownership | Jul 16, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 16, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jul 16, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 15, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 19, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | May 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2026 | Current report | SEC |
| ARS · Annual report to shareholders | Apr 28, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 28, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 28, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 10, 2026 | Insider trade | SEC |
| 10-K · Annual report | Mar 30, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 10, 2026 | Big-stake notice | SEC |
| S-8 · Registration statement for employee plans | Jan 26, 2026 | Offer document | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2026 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Jan 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 29, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Oct 21, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 16, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Sep 22, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 10, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 9, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 3, 2025 | Current report | SEC |
| 8-K · Current report | Aug 18, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Aug 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jul 31, 2025 | Current report | SEC |
| 4/A · Change in ownership, amended | Jul 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 18, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 18, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 17, 2025 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Jun 16, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | May 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 27, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 22, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | May 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 21, 2025 | Insider trade | SEC |
| 8-K · Current report | May 15, 2025 | Results | SEC |
| 10-Q · Quarterly report | May 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2025 | Current report | SEC |
| ARS · Annual report to shareholders | Apr 30, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 30, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 30, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2025 | Insider trade | SEC |
| 8-K · Current report | Apr 9, 2025 | Current report | SEC |
| 4 · Change in ownership | Apr 4, 2025 | Insider trade | SEC |
| 10-K · Annual report | Mar 27, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 17, 2025 | Current report | SEC |
| 8-K · Current report | Jan 21, 2025 | Management or board change | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 16, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 16, 2025 | Current report | SEC |
| S-8 · Registration statement for employee plans | Jan 16, 2025 | Offer document | SEC |
| 4/A · Change in ownership, amended | Dec 23, 2024 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 13, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 11, 2024 | Other filings | SEC |
| 4 · Change in ownership | Nov 12, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2024 | Other filings | SEC |
| 8-K · Current report | Nov 6, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Nov 6, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 6, 2024 | Management or board change | SEC |
| 8-K · Current report | Aug 15, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 13, 2024 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Aug 2, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jun 25, 2024 | Insider trade | SEC |
| 8-K · Current report | Jun 25, 2024 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Jun 13, 2024 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Jun 13, 2024 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2024 | Material contract | SEC |
| 8-K · Current report | May 1, 2024 | Current report | SEC |
| ARS · Annual report to shareholders | Apr 29, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 29, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 29, 2024 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Apr 17, 2024 | Insider trade | SEC |
| 424B5 · Prospectus | Apr 8, 2024 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Mar 29, 2024 | Offer document | SEC |
| 10-K · Annual report | Mar 29, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 26, 2024 | Current report | SEC |
| 424B5 · Prospectus | Jan 19, 2024 | Offer document | SEC |
| 4 · Change in ownership | Jan 4, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jan 4, 2024 | Insider trade | SEC |
| 8-K · Current report | Jan 2, 2024 | Management or board change | SEC |
| 8-K · Current report | Dec 14, 2023 | Current report | SEC |
| 8-K · Current report | Nov 16, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Oct 31, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 26, 2023 | Insider trade | SEC |
| 8-K · Current report | Oct 6, 2023 | Current report | SEC |
| 8-K · Current report | Sep 21, 2023 | Current report | SEC |
| 4 · Change in ownership | Sep 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Sep 14, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 14, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Aug 11, 2023 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Jul 20, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 17, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 14, 2023 | Other filings | SEC |
| S-1 · Registration statement | Jul 7, 2023 | Offer document | SEC |
| 8-K · Current report | Jun 15, 2023 | Meeting outcome | SEC |
| 8-K · Current report | Jun 12, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Jun 9, 2023 | Offer document | SEC |
| 8-K · Current report | May 15, 2023 | Current report | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Apr 28, 2023 | Other filings | SEC |
| 8-K · Current report | Apr 27, 2023 | Current report | SEC |
| CORRESP · Letter to the SEC | Apr 25, 2023 | Other filings | SEC |
| S-3/A · Registration statement, amended | Apr 25, 2023 | Offer document | SEC |
| DEFA14A · Additional proxy material | Apr 25, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 25, 2023 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | Apr 20, 2023 | Other filings | SEC |
| 8-K · Current report | Apr 14, 2023 | Material contract | SEC |
| S-3 · Registration statement | Apr 14, 2023 | Offer document | SEC |
| ARS · Annual report to shareholders | Apr 14, 2023 | Annual report | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Precipio, Inc.’s releases · as of Nov 6, 2026
- Common shares
- 1,792,935
- Fully diluted
- 1,792,935
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 1,792,935 | Nov 6, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Nov 6, 2026 | 1,792,935 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kathleen LaPorte Other companies: Q32 Bio Inc. (Director · Since at least Mar 25, 2024); 89bio Inc (Director · Since at least Nov 1, 2021); CERo Therapeutics Holdings, Inc. (Director · Since at least Oct 5, 2021); Bolt Biotherapeutics, Inc. (Director · Since at least Feb 4, 2021); Paratek Pharmaceuticals Inc (Director · Jan 30, 2009 – Jan 24, 2012 · Past); Affymax Inc (Director · Dec 14, 2006 – Dec 14, 2012 · Past); eHealth, Inc. (Director · Oct 12, 2006 – Oct 12, 2006 · Past); Ista Pharmaceuticals Inc (Director · Jun 22, 2006 – Apr 13, 2011 · Past); Adeza Biomedical Corp (Director · Jun 6, 2006 – Jun 6, 2006 · Past); Vnus Medical Technologies Inc (Director · May 25, 2006 – May 23, 2008 · Past) | Director · Since at least Aug 7, 2018 |
| Douglas Carl Fisher Other companies: CERo Therapeutics Holdings, Inc. (President · Oct 5, 2021 – Feb 14, 2024 · Past); Sera Prognostics, Inc. (Chief Business Officer · Jul 14, 2021 – Jan 10, 2022 · Past); Vyome Holdings, Inc. (Director · Oct 5, 2016 – Sep 16, 2020 · Past) | Director · Sep 26, 2017 – Oct 27, 2023 · Past |
| Mark P Colonnese Other companies: Bio-Path Holdings, Inc. (Director · Jul 13, 2017 – Mar 28, 2019 · Past); Vaxart, Inc. (Chief Financial Officer · Nov 2, 2015 – Apr 3, 2017 · Past); Atherogenics Inc (VP Commercial Operations & CFO · Feb 21, 2006 – Dec 31, 2008 · Past) | Chief Financial Officer · Sep 12, 2012 – Feb 18, 2014 · Past |
| Richard Sandberg Other companies: Oxford Immunotec Global PLC (Director · Nov 21, 2013 – Mar 8, 2021 · Past); Ethan Allen Interiors Inc. (Director · Jul 25, 2006 – Jul 24, 2009 · Past); North American Scientific Inc (Director · May 3, 2006 – Apr 29, 2008 · Past) | Chairman of the Board · Since at least Dec 3, 2019 |
| Ronald Andrews Other companies: Plus Therapeutics, Inc. (Director · Since at least Mar 20, 2026); Insight Molecular Diagnostics Inc. (Former CEO, Director · Jul 1, 2019 – Dec 1, 2022 · Past); Oxford Immunotec Global PLC (Director · Jun 18, 2019 – Mar 8, 2021 · Past) | Director · Since at least Mar 1, 2021 |
| Samuel Riccitelli Other companies: OrthoPediatrics Corp. (Director · Since at least Dec 14, 2017); Viridian Therapeutics, Inc. (President & CEO, Director · Jun 17, 2014 – Oct 31, 2016 · Past); Genoptix Inc (Ex VP and COO · Oct 29, 2007 – Mar 7, 2011 · Past) | Director · Jun 29, 2017 – Mar 18, 2019 · Past |
| Antonius Schuh Other companies: Cardiff Oncology, Inc. (CEO, Director · Jan 23, 2012 – Jan 4, 2016 · Past); Sorrento Therapeutics, Inc. (Chairman and CEO, Director · Feb 16, 2010 – Feb 16, 2010 · Past) | Director · May 20, 2009 – Feb 18, 2014 · Past |
| Christina Valauri Other companies: Valion Bio, Inc. (Director · Since at least Jul 1, 2024) | Director · Since at least Jan 2, 2024 |
| Ilan Danieli Other companies: Osiris Corporation (Chief Operating Officer · Apr 1, 2008 – Apr 1, 2008 · Past) | CEO · Since at least Jun 29, 2017 |
| Michael A Luther Other companies: Albany Molecular Research Inc (Senior VP, Discovery Services · Oct 28, 2013 – Feb 4, 2015 · Past) | Director · Mar 13, 2014 – Feb 16, 2018 · Past |
All 38 people
| Person | Seat |
|---|---|
| Rodney S Markin Other companies: Cardiff Oncology, Inc. (Director · Since at least Feb 19, 2014) | Director · Mar 1, 2007 – Feb 18, 2014 · Past |
| Ahmed Zaki Sabet | Chief Operating Officer · Since at least Dec 2, 2019 |
| Ayman Mohamed | CTO · Since at least Nov 5, 2026 |
| A. Zaki Sabet | COO · Since at least Jun 11, 2026 |
| Brett L Frevert | Chief Financial Officer · Jun 30, 2010 – May 18, 2011 · Past |
| Carl Iberger | Chief Financial Officer · Jun 29, 2017 – Jan 11, 2022 · Past |
| Chad M Richards | Chief Commercial Officer · Jun 15, 2012 – Jun 15, 2012 · Past |
| Craig James Tuttle | President and CEO, Director · Jul 12, 2006 – May 3, 2013 · Past |
| David P Pauluzzi | Director · Jan 2, 2008 – Mar 10, 2008 · Past |
| David S. Cohen | Director · Since at least Nov 8, 2017 |
| Debra A Schneider | Vice President and CFO · Dec 4, 2006 – Dec 7, 2007 · Past |
| Doit Koppler II | Director · Dec 29, 2010 – Dec 13, 2016 · Past |
| Eric P Kaldjian | Chief Scientific Officer · May 21, 2008 – Dec 9, 2008 · Past |
| Frank R Witney | Director · Apr 9, 2007 – May 21, 2008 · Past |
| Gregory T Sloma | Director · Sep 1, 2006 – Jun 7, 2010 · Past |
| Jeffrey Cossman | Director · Since at least Sep 26, 2017 |
| Jeffrey L Sklar | Director · Sep 1, 2006 – Jun 7, 2010 · Past |
| John D Thompson | Director · May 14, 2014 – Apr 1, 2015 · Past |
| Kathy LaPorte | Director · Since at least Nov 4, 2026 |
| Mark Rimer | Director · Sep 8, 2017 – Jan 11, 2022 · Past |
| Matthew Gage | CFO · Since at least Mar 21, 2022 |
| Michael B McNulty | Director · May 20, 2009 – Jun 7, 2010 · Past |
| Miri Chiko-Radomski | Chief Legal Counsel and People Officer · Since at least Nov 5, 2026 |
| Mya Thomae | Director · Jun 8, 2015 – Dec 13, 2016 · Past |
| Paul Kinnon | CEO, President and Interim CFO, Director · Sep 30, 2013 – Apr 1, 2015 · Past |
| Robert Patzig | Director · Dec 29, 2010 – Sep 26, 2017 · Past |
| Roland J Santoni | Director · Sep 1, 2006 – Nov 20, 2006 · Past |
| Ron A. Andrews | Director · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about Precipio, Inc.